高级检索

社区管理干预对非酒精性脂肪性肝病改善效果的IMB模型评价

Evaluation of the effectiveness of community-based management interventions based on the IMB model in ameliorating non-alcoholic fatty liver disease

  • 摘要:
    目的 评价基于信息—动机—行为技巧模型(IMB)的社区管理干预对非酒精性脂肪性肝病(NAFLD)的改善效果,为探索基层卫生服务中NAFLD健康管理路径提供参考依据。
    方法 于2023年1—4月在浙江省嘉兴市东栅街道社区卫生服务中心招募714例50~69岁参加体检并确诊患有NAFLD者,将其随机分为对照组和干预组2组,每组各357例,对照组发放健康教育手册,干预组在此基础上给予基于IMB模型的生活方式综合干预,干预1年后比较2组NAFLD患者干预前、后肝脏受控衰减指数(CAP)、肝脏硬度值(LSM)、体重、体质量指数(BMI)、腰围、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、谷草转氨酶(AST)、谷丙转氨酶(ALT)和空腹血糖(GLU)的变化情况。
    结果 对照组与干预组NAFLD患者CAP、LSM、体重、BMI、腰围、TC、TG、LDL-C、HDL-C、AST、ALT、GLU在干预前分别为(280.75±35.45)和(287.07±37.81)dB/m、(5.83±2.00)和(5.66±1.86)kPa、(67.85±9.90)和(67.64±9.61)kg、(25.99±2.88)和(26.22±2.98)、(89.27±8.12)和(88.85±7.98)cm、(5.10±0.97)和(5.18±1.08)mmol/L、(2.35±1.58)和(2.44±2.45)mmol/L、(2.83±0.73)和(2.88±0.77)mmol/L、(1.28±0.33)和(1.28±0.33)mmol/L、(24.31±9.39)和(24.88±9.38)U/L、(26.47±17.68)和(26.84±15.04)U/L、(6.29±1.84)和(6.40±2.27)mmol/L。在干预后分别为(277.06±43.59)和(265.34±41.39)dB/m、(5.57±1.76)和(5.30±1.75)kPa、(66.05±9.79)和(64.11±10.11)kg、(25.38±2.91)和(25.10±3.03)、(88.01±8.06)和(85.30±8.93)cm、(5.17±1.17)和(5.01±1.08)mmol/L、(2.26±1.90)和(1.98±1.48)mmol/L、(2.97±0.80)和(2.89±0.79)mmol/L、(1.38±0.34)和(1.44±0.33)mmol/L、(22.80±8.39)和(22.25±6.74)U/L、(24.87±13.52)和(23.85±13.05)U/L、(6.21±1.61)和(5.98±1.51)mmol/L。干预前、后对照组和干预组NAFLD患者分别比较,干预前、后对照组NAFLD患者LSM、体重、BMI、腰围、LDL-C、HDL-C、AST和ALT差异均有统计学意义(均P<0.05)。干预前、后干预组NAFLD患者CAP、LSM、体重、BMI、腰围、TC、TG、HDL-C、AST、ALT和GLU差异均有统计学意义(均P<0.01)。干预前2组NAFLD患者CAP差异有统计学意义(t= −2.214,P=0.027)。干预后2组NAFLD患者CAP、体重、腰围、TG和HDL-C差异均有统计学意义(均P<0.05)。
    结论 基于IMB模型的社区管理干预能有效改善NAFLD患者的肝脂肪病变水平以及体重和腰围,并改善TG和HDL-C血脂水平。

     

    Abstract:
    Objective To evaluate the effectiveness of a community-based management intervention based on the Information-Motivation-Behavioral Skills (IMB) model in ameliorating non-alcoholic fatty liver disease (NAFLD), providing a reference for exploring the health management pathways for NAFLD in primary health service centers.
    Methods Between January and April 2023, 714 NAFLD patients aged 50–69 years and diagnosed during physical examinations were recruited from the Community Health Service Center of Dongzha Street in Jiaxing, Zhejiang. The participants were randomly allocated into a control group (n = 357) and an intervention group (n = 357). The control group received health education manuals, while the intervention group additional received a comprehensive lifestyle intervention based on the IMB model. The controlled attenuation parameter (CAP), liver stiffness measurement (LSM), body weight, body mass index (BMI), waist circumference, total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and fasting blood glucose (GLU) were compared between the two groups before and after the 1-year intervention.
    Results The CAP, LSM, body weight, BMI, waist circumference, TC, TG, LDL-C, HDL-C, AST, ALT, and GLU in the control and intervention groups before intervention were (280.75 ± 35.45) and (287.07 ± 37.81) dB/m, (5.83 ± 2.00) and (5.66 ± 1.86) kPa, (67.85 ± 9.90) and (67.64 ± 9.61) kg, (25.99 ± 2.88) and (26.22 ± 2.98), (89.27 ± 8.12) and (88.85 ± 7.98) cm, (5.10 ± 0.97) and (5.18 ± 1.08) mmol/L, (2.35 ± 1.58) and (2.44 ± 2.45) mmol/L, (2.83 ± 0.73) and (2.88 ± 0.77) mmol/L, (1.28 ± 0.33) and (1.28 ± 0.33) mmol/L, (24.31 ± 9.39) and (24.88 ± 9.38) U/L, (26.47 ± 17.68) and (26.84 ± 15.04) U/L, and (6.29 ± 1.84) and (6.40 ± 2.27) mmol/L, respectively. After intervention, the values were (277.06 ± 43.59) and (265.34 ± 41.39) dB/m, (5.57 ± 1.76) and (5.30±1.75) kPa, (66.05 ± 9.79) and (64.11 ± 10.11) kg, (25.38 ± 2.91) and (25.10 ± 3.03), (88.01 ± 8.06) and (85.30 ± 8.93) cm, (5.17 ± 1.17) and (5.01 ± 1.08) mmol/L, (2.26 ± 1.90) and (1.98 ± 1.48) mmol/L, (2.97 ± 0.80) and (2.89 ± 0.79) mmol/L, (1.38 ± 0.34) and (1.44 ± 0.33) mmol/L, (22.80 ± 8.39) and (22.25 ± 6.74) U/L, (24.87 ± 13.52) and (23.85 ± 13.05) U/L, (6.21 ± 1.61) and (5.98 ± 1.51) mmol/L respectively. The control group of NAFLD patients showed differences in LSM, body weight, BMI, waist circumference, LDL-C, HDL-C, AST, and ALT before and after intervention (all P < 0.05). The intervention group of NAFLD patients showed differences in CAP, LSM, body weight, BMI, waist circumference, TC, TG, HDL-C, AST, ALT, and GLU before and after intervention (all P < 0.01). Before intervention, the two groups showed differences in CAP (t = −2.214, P = 0.027). After intervention, the two groups of NAFLD patients showed differences in CAP, body weight, waist circumference, TG, and HDL-C (all P < 0.05).
    Conclusions The community-based management intervention based on the IMB model effectively reduced hepatic steatosis, body weight, and waist circumference and recovered serum levels of lipids such as TG and HDL-C in NAFLD patients.

     

/

返回文章
返回